Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $80.43 Million |
|---|---|
| Enterprise Value | $109.96 Million |
| Earnings per Share | $-0.4 |
| Beta | 0.82 |
| Outstanding Shares | 30,884,465 |
| P/E Ratio | -12 |
|---|---|
| PEG | 27.18 |
| Price to Sales | 2.62 |
| Price to Book Ratio | 2.62 |
| Enterprise Value to Revenue | 1.94 |
| Enterprise Value to EBIT | -36.91 |
| Enterprise Value to Net Income | -17 |
| Total Debt to Enterprise | 0.37 |
| Debt to Equity | 0.81 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
HLS Therapeutics Inc. operates as a specialized pharmaceutical firm, concentrating on the acquisition and commercialization of medicinal products, primarily within the niche central nervous system (CNS) and cardiovascular (CV) sectors. I...